Breast screening is the regular examination of a woman's breasts to find breast cancer in an initial stage. The sole exam approved for this purpose is mammography that, despite the existence of more advanced technologies, is considered the cheapest and most efficient method to detect cancer in a preclinical stage. We investigate, using machine learning techniques, how attributes obtained from mammographies can relate to malignancy. In particular, this study focus is on how mass density can influence malignancy from a data set of 348 patients containing, among other information, results of biopsies. To this end, we applied different learning algorithms on the data set using the WEKA tools, and performed significance tests on the results. The conclusions are threefold: (1) automatic classification of a mammography can reach equal or better results than the ones annotated by specialists, which can help doctors to quickly concentrate on some specific mammogram for a more thorough study; (2) mass density seems to be a good indicator of malignancy, as previous studies suggested; (3) we can obtain classifiers that can predict mass density with a quality as good as the specialist blind to biopsy.
INTRODUCTION
Breast screening is the regular examination of a woman's breasts to find breast cancer earlier. The sole exam approved for this purpose is mammography. Usually, findings are annotated through the Breast Imaging Reporting and Data System (BIRADS) created by the American College of Radiology. The BI-RADS system determines a standard lexicon to be used by radiologists when studying each finding. Despite the existence of more advanced technologies, mammography is considered the cheapest and most efficient method to detect cancer in a preclinical stage.
In this work, we were provided with 348 cases of patients that went through mammography screening. Our main objective is to apply machine learning techniques to these data in order to find non trivial relations among attributes, and learn models that can help medical doctors to quickly assess mammograms.
Much work has been done on applying machine learning techniques to the study of breast cancer, which is one of the most common kinds of cancer in the world. In the UCI (University of California, Irvine) machine learning repository (http:// archive.ics.uci.edu/ml/datasets.html) there are four data sets whose main target of study is breast cancer. One of the first works on applying machine learning techniques to breast cancer data dates from 1990. The data set used in this study, donated to the UCI repository, was created by Wolberg and Mangasarian after their work on a multisurface method of pattern separation for medical diagnosis applied to breast cytology (Wolberg and Mangasarian, 1990) . Most works in the literature applies artificial neural networks to the problem of diagnosing breast cancer (e.g., (Wu et al., 1993) and (Abbass, 2002) ). Others focus on prognostic of the disease using inductive learning methods (e.g., (Street et al., 1995) ). More recently, Ayer et al. (Ayer et al., 2010) have evaluated whether an artificial neural network, trained on a large prospectively collected data set of consecutive mammography findings, could discriminate between benign and malignant disease, and accurately predict the probability of breast cancer for individual patients.
Other recent studies focus on extracting information from free text that appears in medical records of mammography screenings (Nassif et al., 2009) , and on the influence of age in ductal carcinoma in situ (DCIS) findings (Nassif et al., 2010) . Our study is focused on the influence of mass density on predicting malignancy, but we also uncover other interesting complementary findings. Previous works by Jackson et al. (Jackson et al., 1991) and Cory and Linden (Cory and Linden, 1993) have argued that, although the majority of high density masses are malignant, the presence of low density cancers and more important indicators (like margins, shape, and associated findings) make mass density a less reliable indicator or predictor of malignancy. Sickles (Sickles, 1991) has the same opinion. A study carried out by Davis et al. (Davis et al., 2005) indicated that mass density could have more importance and relevance than previous works had reported. In another work, Woods et al. ) applied inductive logic programming to a set of breast cancer data and concluded the same thing. Woods and Burnside (Woods and Burnside, 2010 ) also applied logistic regression and kappa statistics to another set of breast cancer data and concluded that mass density and malignancy are somewhat related.
In this work, we use the same data set used by Woods and Burnside (Woods and Burnside, 2010 ), but we apply machine learning methods and confirm the findings of Woods and Burnside. In addition, we show that the learned classifiers generated in this work can predict mass density and outcome (classification of a mammography) with a quality as good as a specialist, proving to be good helpers to medical doctors when evaluating mammograms.
BREAST CANCER DATA
Our study analyzes 348 consecutive breast masses that underwent image guided or surgical biopsy performed between October 2005 and December 2007 on 328 female subjects. All 348 biopsy masses were randomized and assigned to a radiologist blinded to biopsy results for retrospective assessment using the Breast Imaging Reporting and Data System (retrospectively-assessed data set). Clinical radiologists prospectively assessed the density of 180 of these masses (prospectively-assessed data set). Pathology result at biopsy was the study endpoint.
The atributes included in our study are very much the ones collected by the radiologists from the mammograms, and are based on the BIRADS lexicon. We selected from the original database all the attributes considered relevant by the specialists and removed some attributes such as identifiers, redundant attributes and attributes that had the same value for all instances. For our main task, to predict malignancy, our class attribute was the outcome binary variable assuming values benign or malignant.
From the 348 cases, 118 are malignant (≈ 34%), and 84 cases have high mass density (≈ 24%) retrospectively assessed. Other attributes are mass shape, mass margins, depth, size, among others. For the purpose of our study, we have two attributes that represent the same characteristics of the finding, but with different interpretations. These are retro density and density num. Both represent mass densities that can assume values high or iso/low. Retro density was retrospectively assessed while density num was prospectively (at the time of imaging) assessed.
EXPERIMENTS AND RESULTS
Our first preliminary study was to calculate simple frequencies from the data and to determine if there was some evidence of relationship between attributes, specially, the main focus of our study:
Is mass density related to malignancy?
As mentioned above, from the 348 breast masses, 118 are malignant (≈ 34%), and 84 have high mass density (≈ 24%). If we consider that mass density and malignancy are independent, and take 84 cases from the 348 at random, the probability of these being malignant should still be ≈ 34%. However, if it happens that all 84 cases selected at random have high density, then the percentage of malignant cases raises to 70.2% (this is the percentage of cases that are both malignant and have high mass density). The probability of this being coincidence is very low, given the data distribution. This simple calculation may already imply that high density has some relation to malignancy. So may imply that other attributes such as age, mass shape and mass margins can have some relation to malignancy. One of the objectives of our study is then to confirm if these attributes have some relation to the outcome variable.
Methods
As mentioned before, the data set used in the experiments contains 348 findings that include data related to biopsies. A subset of 180 was annotated by a specialist blind to the biopsies results. The task of this specialist was to annotate the mass density. The remaining findings, 168 cases, were not annotated by this specialist.
All experiments were performed using the WEKA tool, developed at Waikato University, New Zealand (Hall et al., 2009 ). We experimented with several classification algorithms, but report only for the algorithms that produced the best results. The experiments were performed in WEKA using the Experimenter module, where we set several parameters, including the statistical significance test and confidence interval, and the algorithms we wanted to use (we used OneR as reference, ZeroR, PART, J48, SimpleCart, DecisionStump, Random Forests, SMO, Naive Bayes, Bayes with TAN, NBTree and DTNB). The WEKA experimenter produces a table with the performance metrics of all algorithms with an indication of statistical differences, using one of the algorithms as a reference. The significance tests were performed using standard corrected t-test with a significance level of 0.01. The parameters used for the learning algorithms are the WEKA defaults. In the tables, the numbers between parentheses represent standard deviations. From the 348 cases, we trained on the 180 annotated cases. We used the remaining 168 as unseen/test data to evaluate the performance of the classifiers. During the training, we used 10-fold stratified cross validation and reported the results for the average metrics obtained among all folds.
Is mass density predictive of malignancy?
We considered at least two ways of investigating if mass density is predictive of malignancy. The first one is to apply association rules or logistic regression to the 348 findings, and report the relation between retro density and outcome. This was already done by Woods and Burnside (Woods and Burnside, 2010) , in a previous work, using logistic regression and kappa statistics. Their results showed that high mass density is a relatively important indicator of malignancy with an inter-observer agreement of 0.53. The second way is to use a classification method and predict outcome using mass density and without using mass density and compare results. As we have two kinds of mass density: one for the retrospective data and another one for the prospective data, we used both to build classifiers. Our first experiment was then to generate a classifier to predict outcome with retro density using 10-fold cross-validation on the 180 findings. Our second experiment was to generate a classifier to predict outcome with density num (prospectively assessed), also using 10-fold crossvalidation on the 180 findings.
In order to investigate if mass density is predictive of malignancy, we also generated a classifier to predict outcome without any information about density using 10-fold cross-validation on the 180 findings.
In the three experiments, the best classifiers found were based on Support Vector Machines (Platt, 1998) . Table 1 summarizes the results obtained using the metrics we found more relevant to the task. CCI is the percentage of Correctly Classified Instances. K is the k-value of kappa statistics. Prec is the Precision, and F is the F-measure. These results show that mass density has some influence on the outcome, specially when mass density is the one observed on the retrospective data. The classifier trained without mass density has an overall performance of 81.39% while the classifier trained with the retrospective assessed mass has an overall performance of 84.78%. These results are statistically different (p=0.01). If we look at the K value, we can confirm that the relation between mass density and outcome is not by chance, given the relatively high observed agreement between the real data and the classifier's predicted values. With respect to Precision, the results also seem to be quite good with only 16% of cases being incorrectly classified as malignant when using the retrospective data. The Recall also gives a reasonable rate of correctly classified cases of malignancy, although there is still scope for improvement. The f-measure balances the values of Precision and Recall and also indicates that the classifiers are behaving reasonably well.
Summarising, these results show that attributes other than mass density are also important, but if we add mass density, the classifier's performance improves.
These results also confirm findings in the literature regarding the relevance of mass density, and show that good classifiers can be obtained to predict outcome (with a high percentage of correctly classified instances and good values of K, precision and recall).
Can we obtain a classifier that predicts mass density as well as the radiologist?
Our second question is related to the quality of the classifier related to a specialist. As we have two annotated mass densities, one for the prospective study and another one for the retrospective, we generated 2 classifiers: one is trained on the prospective values of mass density (density num), and another one is trained on the retrospective (retro density) values of mass density. Once more, we used the 180 cases as training set and 10-fold stratified cross-validation. The best classifier obtained by the WEKA Experimenter for these two tasks was based on NaiveBayes (John and Langley, 1995) . Table 2 shows the results of these experiments as an average of the metrics for the 10 folds. 70% of masses annotated by the specialist on the 180 findings agreed to the annotated masses of the retrospective study. The Naive Bayes classifier predicted ≈ 73% of correct instances when training on the retrospective annotated mass (retro density) and ≈ 67% when training on prospective masses annotated by a radiologist. These results are quite good and indicate that the Bayesian classifier generated in this study can be well applied as a support tool to help doctors predicting mass density for unseen mammograms. The values of K, Precision, Recall and fmeasure for this experiment are not so good as the ones obtained when trying to learn outcome. However, the K value indicates that the Naive Bayes classifier has some level of agreement with the actual data, which is not by chance. One interesting thing to observe is that, although the classifier trained on the retrospective data has a higher rate of correctly classified instances, it has lower values for Precision, Recall and f-measure than the classifier trained on the prospective data. This may indicate that this could be a better classifier to be used when one does not have information about the biopsy data.
Our last question is related to how well a learned classifier can predict the outcome (malignant or benign) on unseen data blind to the result of the biopsy.
Can the generated classifiers behave well on unseen data?
In order to answer this question we need again to consider classifiers generated using the retrospective mass density attribute and the prospective mass density attribute. The first classifier, based on the retrospective values of mass density was generated when training on the 180 findings to answer our first question: "is mass density related to malignancy?" This is a classifier based on Support Vector Machines. However, we can use yet another classifier, based on the prospective values of mass density to predict the 168 unseen cases. As the 168 unseen cases do not have any prospective annotated mass density, we will fill up these missing values using the classifiers generated when answering our question 2 (Subsection 3.3).
In those experiments, we generated two classifiers to predict mass density: one that was trained on retro density and another one that was trained on density num. Both are Bayesian classifiers. Once we fill up these values, we can apply a classifier learned to predict outcome to this unseen data set.
Results of the prediction of mass density on the unseen data are shown in Table 3 . These results were produced by the best classifier that was, in both cases, a naive Bayes network. These results are very good, given that both classifiers have a prediction performance on the unseen data well above the one obtained on the training set (180 cases) with respect to CCI. The K-statistics and the Recall also improved on the unseen data. We see a slightly fall in performance when predicting benign cases, and this is observed by the precision and fmeasure values in the unseen data. The rate of false positives increases on the unseen data. On the other hand, the algorithm performs better on classifying the malignant cases.
Once the predicted values of mass densities of the 168 findings are filled, we move to the next step, which is to predict outcome for the unseen data. Results of this experiment can be found in Table 4 .
In Table 4 we show three different predictions for outcome, using three different sources for the mass density. The second column in Table 4 shows the results of predicting outcome using the attribute for mass density available on the retrospective data (retro density attribute). The third and fourth columns show the predictions when using the mass density filled up by the two Naive Bayes classifiers (one that was trained on the retro density attribute and another that was trained on the prospective density num attribute).
Regarding the comparison among these three predictions we can observe that the three classifiers behaved relatively well on the unseen data, capturing most of the malignant and benign cases. The K value, once more, indicates that those results are not by chance. In other words, the classifiers are actually helping to distinguish between malignant and benign cases. As observed before, the classifier trained on the actual retrospective data yields better performance, but the other classifiers are not performing that far, which indicates that the lack of biopsy data is not harming the classification task.
A second observation we take from these results is that, even using predicted values for mass density (with prediction errors), the classifiers for outcome in columns three and four, can maintain a reasonable performance.
The last conclusion we take from these results is that mass density is somehow related to outcome, and is an important attribute that contributes to improve the performance of the classifiers. A comparison between the figures on the last column of Table 4 (prediction without mass density) with the figures on the other columns confirms that fact.
Summarizing, and getting back to our third question "3. Can we obtain a classifier that predicts mass density as well as the radiologist?", Table 5 shows the performance of all classifiers used for this task on the training data and on unseen data. Table 5 summarizes our results for predicting mass density and shows that the classifiers generated have a good performance that in some cases is better than the one given by the radiologist. The performance on unseen cases is also quite reasonable regarding the precision and recall values.
CONCLUSIONS AND FUTURE WORK
In this work, we were provided with 348 cases of patients that went through mammography screening. The objective of this work was twofold: i) find non trivial relations among attributes by applying machine learning techniques to these data, and; ii) learn models that could help medical doctors to quickly assess mammograms. We used the WEKA machine learning tool and whenever applicable performed statistical tests of significance on the results.
The conclusions are threefold: (1) automatic classification of a mammography can reach equal or better results than the ones annotated by specialists; (2) mass density seems to be a good indicator of malignancy, as previous studies suggested; (3) machine learning classifiers can predict mass density with a quality as good as the specialist blind to biopsy.
As future work, we plan to extend this work to larger data sets, and apply other machine learning techniques based on statistical relational learning, since classifiers that fall in this category provide a good explanation of the predicted outcomes as well as can consider the relationship among mammograms of the same patient. We would also like to investigate how other attributes can affect malignancy or are related to the other attributes. 
